hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (FDA) to manufacture ibuprofen and famotidine tablets, 800 mg/26.6 mg. (USRLD: Duexis ...
Zydus Lifesciences Ltd has bagged final approval from the US Food and Drug Administration (USFDA) to produce and market Dasatinib tablets in the US. The approved strengths are 20 mg, 50 mg ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results